Trial Outcomes & Findings for Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease (NCT NCT00949403)
NCT ID: NCT00949403
Last Updated: 2020-06-22
Results Overview
Liver fatty acid oxidation as determined by 1-11C-palmitate PET imaging.
Recruitment status
COMPLETED
Study phase
EARLY_PHASE1
Target enrollment
9 participants
Primary outcome timeframe
3 hours
Results posted on
2020-06-22
Participant Flow
Participant milestones
| Measure |
Obese Females (Pre-bariatric Surgery)
Twenty obese females (18-45 years of age, BMI \> or equal to 45) who are scheduled to undergo bariatric surgery at Barnes-Jewish Hospital will be screened for enrollment over 2 years.
|
|---|---|
|
Overall Study
STARTED
|
9
|
|
Overall Study
COMPLETED
|
9
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 3 hoursPopulation: The PI has left the institution, all efforts to locate the data have been exhausted and therefore no results are available to be reported.
Liver fatty acid oxidation as determined by 1-11C-palmitate PET imaging.
Outcome measures
Outcome data not reported
Adverse Events
Obese Females (Pre-bariatric Surgery)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory
Washington University School of Medicine
Phone: 314-747-3877
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place